PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.69
arrow_downward
-0.37%(-0.0100) 1D
$2.70
arrow_upward
+0.37% (+0.0100)bedtimeAfter hours
Closed: Sep 18, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLX...
Open
$2.68
High
$2.72
Low
$2.66
Mkt. cap
216.74M
Avg. vol.
787.06K
Volume
1.25M
P/E ratio
11.89
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
0.02
Shares outstanding
80.57M
No. of employees
226
Open
$2.68
High
$2.72
Low
$2.66
Mkt. cap
216.74M
Avg. vol.
787.06K
Volume
1.25M
P/E ratio
11.89
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
0.02
Shares outstanding
80.57M
No. of employees
226
News stories
From web sources and news partners
CarePlus VietNam
·
1 month ago
PLX Q1 2026 Earnings: EPS Shocks Estimates at $0.22, Revenue Picture Remains Unclear - Basic EPS Analysis
CarePlus VietNam
·
1 month ago
PLX Q1 2026 Earnings: Stunning EPS Beat Overshadowed by Stock Decline - Earnings Preview
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com